ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,308 | -36.2% | 12,400 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $61,628 | -49.9% | 12,400 | +9.3% | 0.00% | -66.7% |
| Q3 2022 | $123,000 | -34.9% | 11,350 | -31.4% | 0.00% | -25.0% |
| Q2 2022 | $189,000 | +38.0% | 16,550 | +10.0% | 0.00% | +100.0% |
| Q1 2022 | $137,000 | -23.9% | 15,050 | +24.9% | 0.00% | -33.3% |
| Q4 2021 | $180,000 | -46.7% | 12,050 | -8.3% | 0.00% | -50.0% |
| Q3 2021 | $338,000 | -12.9% | 13,145 | -11.7% | 0.01% | -14.3% |
| Q2 2021 | $388,000 | -56.1% | 14,884 | -40.5% | 0.01% | -61.1% |
| Q1 2021 | $883,000 | +240.9% | 25,023 | +88.1% | 0.02% | +125.0% |
| Q1 2020 | $259,000 | +27.6% | 13,300 | +70.5% | 0.01% | +60.0% |
| Q4 2019 | $203,000 | -60.2% | 7,800 | -58.3% | 0.01% | -64.3% |
| Q3 2019 | $510,000 | +86.1% | 18,700 | +83.3% | 0.01% | +100.0% |
| Q2 2019 | $274,000 | – | 10,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
| Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
| TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
| Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
| Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
| HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
| Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
| Navalign, LLC | 74,271 | $623,000 | 0.26% |
| PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |